Global Clinical Trial Industry Is Expected to Grow Steadily, Reaching US$184.61 Billion at a 4.3% CAGR by 2034 | FMI

Global Clinical Trial Industry

Global Clinical Trial Industry

The Global Clinical Trial Industry is projected to reach a value of US$184.61 billion by 2034, according to a recent market analysis. While the growth is anticipated to be steady, with a Compound Annual Growth Rate (CAGR) of 4.3%, the market holds significant potential for the coming decade.

Both governmental and private sponsorship of clinical trials is helping them increase in number. As the number of diseases and patients increases, there is more demand for research to come up with newer medicines and treatments. The rise in cancer patients is especially necessitating the development of more oncology clinical trials.

Clinical trials are making use of advanced technology like AI and machine learning. These technologies are helping researchers handle data, select better samples, save time, and increase effectiveness. Technology is also allowing researchers to conduct virtual trials, a holdover from the pandemic era that is still going strong.

There are, however, impediments to market growth. While more people are open to being a part of trials, sometimes researchers struggle to find the right candidates with the right symptoms or afflictions. The complex process of clinical trials, requiring significant funding, is also a roadblock in the path of the market.

“Clinical trials are no longer relegated to just labs as decentralized trials that are more convenient for the subjects are emerging as a significant trend. Outsourcing lab work to countries like India and Brazil is also being practiced by companies from developed nations. Thus, outsourcing and decentralized trials represent significant opportunities in the market”, says an analyst at FMI.

Request a Sample of this Report Now!

Key Takeaways from the Global Clinical Trial Industry

  • The clinical trial market is projected to be valued at US$ 120.97 billion in 2024.
  • Industry sponsorship is the prevailing mode of sponsorship in the market. In 2024, industry sponsorship is projected to account for 55.0% of the market share.
  • Oncology is the prime area of concern for clinical trials. For 2024, oncology is anticipated to account for 29.7% of the market share by area.
  • Germany is one of the most promising countries for the market. For the forecast period, the CAGR for Germany is estimated to be 5.6%.
  • The United Kingdom is another European country with a bright future for the market. The CAGR for the United Kingdom is anticipated to be 4.7% for the forecast period.
  • The market is expected to register a CAGR of 5.0% in the United States over the forecast period.

Competition Analysis of the Global Clinical Trial Industry

Companies in the market are taking the aid of both private and government sponsorships. The nature of the market is fragmented, with scope for organizations of all scales. Some prominent companies in the market include ICON plc, Charles River Laboratories International, Inc., IQVIA, and SYNEOS HEALTH.

Reach Out to Our Analyst For Your Queries

Recent Developments in the Global Clinical Trial Industry

  • In January 2024, Abbott announced the completion of the first trials of the company’s Volt Pulsed Field Ablation (PFA) System for the treatment of heart rhythm disorders.
  • In August 2023, LG Chem applied to the Italian Medicines Agency for Phase 3 trials of its gout treatment Tigulixostat.

Key Companies in the Global Clinical Trial Industry

  • Pharmaceutical Product Development, INC. (Thermo Fisher Scientific, Inc.)
  • ICON plc
  • Charles River Laboratories International, Inc.
  • SGS SA
  • PAREXEL International Corporation
  • Wuxi AppTec, Inc
  • Chiltern International Ltd (Laboratory Corporation of America)
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Pfizer
  • Clinipace (Caidya)

Click Here To Buy Your Full Report

Global Clinical Trial Industry Key Segments

By Sponsor:

  • Industry
  • Government Organizations
  • Non-Government Organizations
  • Others
  • Associations

By Area:

By Phase:

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Have a Look at the Related Report from the Global Clinical Trial Industry:

The global ePharmacy market is projected to expand at 14.3% CAGR to reach a market valuation of US$ 351.9 billion by the end of 2033, up from the US$ 81.5 billion recorded for 2022.

The ibuprofen API market analysis demonstrates that demand for ibuprofen APIs is valued at around US$ 665 million in 2024 and is on its way to register a CAGR of 2.5% to reach US$ 851 million by 2034.

The global pharmacy refrigerators market is estimated to be valued at US$ 552.3 million in 2022, rising to US$ 1,027 million by 2032 with a CAGR of 5.8 percent during the forecast period.

The mobile cardiac telemetry system market in 2024. Looking ahead to 2034, the current forecast projects a CAGR of 8.30%. Current projections of mobile cardiac telemetry device market imply a valuation of US$ 2,608.30 million by 2034

The pharmacy and drug store franchises market is expected to reach US$ 82.4 Billion in 2023, up from US$ 72 Billion in 2022, reflecting a Y-o-Y growth rate of over 14%. Furthermore, from 2023 to 2033

The molecular diagnostic market indicate an estimation of US$ 60,347.40 million by 2034, climbing up from US$ 39,611.00 million in 2024. After an exhaustive assessment of the market, a moderate CAGR of 4.30% is envisaged through 2034.

The pharmacy automation market valuation is US$ 5.6 billion in 2023. Businesses across different sectors increasingly recognize the transformative potential of the healthcare sector. This lays the groundwork for substantial growth, with estimates suggesting the market to surpass US$ 13.3 billion by 2033.

The non-surgical fat reduction market is set to rise at a CAGR of 5.60% through 2034. The market value is slated to increase from US$ 1700.5 million in 2024 to US$ 2932.3 million by 2034.

In the latest report by Future Market Insights, the lead research consultant estimates the global Neurovascular Device market value to reach US$ 3.0 billion in 2024.

the dosimetry market, FMI has assessed the market valuation to be US$ 3,144.10 million in 2024. The market continues to profit from rapidly increasing conditions like cardiovascular (CVD) diseases, cancer, and neurology-related diseases, which are raising the demand for dosimeters.


Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

Matched content

Editor’s pick

Express Press Release Distribution